Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,134 JPY | +0.78% | -0.10% | +1.97% |
16/05 | Takeda Canada Completes LOI Stage for Post-Transplant Cytomegalovirus Treatment | MT |
15/05 | Takeda Pharmaceutical's Dengue Vaccine Granted WHO Prequalification | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.97% | 41.12B | |
+37.84% | 723B | |
+33.96% | 595B | |
-2.90% | 369B | |
+20.22% | 332B | |
+2.55% | 282B | |
+16.91% | 244B | |
+9.51% | 208B | |
-4.74% | 205B | |
+0.83% | 168B |
- Stock Market
- Equities
- 4502 Stock
- News Takeda Pharmaceutical Company Limited
- Takeda Pharmaceutical : Working With Immusoft to Develop B-Cell Therapies for Rare Neurometabolic Disorders